List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 224 studies with search of:   United States, Alaska
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: clodronate disodium;   Drug: ibandronate sodium;   Drug: zoledronic acid
2 Recruiting Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: vincristine sulfate;   Drug: yttrium Y 90 ibritumomab tiuxetan;   Procedure: radiation therapy
3 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung Cancer
Interventions: Drug: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: vinorelbine ditartrate
4 Active, not recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: filgrastim;   Drug: paclitaxel;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
5 Recruiting Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Condition: Breast Cancer
Intervention: Drug: zoledronic acid
6 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: placebo
7 Completed Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Condition: Hepatitis A
Intervention: Biological: hepatitis A vaccine (HAVRIX)
8 Recruiting Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
Condition: Breast Cancer
Intervention: Procedure: chemotherapy
9 Active, not recruiting Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: tositumomab and iodine I 131 tositumomab;   Drug: vincristine sulfate
10 Active, not recruiting Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: goserelin;   Drug: mitoxantrone hydrochloride;   Drug: prednisone;   Procedure: adjuvant therapy;   Procedure: radiation therapy
11 Active, not recruiting Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: bortezomib;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: vincristine sulfate
12 Recruiting Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: fulvestrant
13 Recruiting Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: filgrastim;   Drug: paclitaxel;   Drug: pegfilgrastim;   Drug: trastuzumab
14 Completed An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
Conditions: Sexual Dysfunctions, Psychological;   Sexual Arousal Disorder
Intervention: Drug: sildenafil
15 Recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: letrozole;   Drug: placebo
16 Active, not recruiting Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Drug: cyclophosphamide
17 Active, not recruiting Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
Interventions: Drug: alphatocopherol;   Drug: Selenium;   Drug: Placebo replacement for vitamin E;   Drug: Placebo replacement for Selenium
18 Active, not recruiting Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: bevacizumab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: adjuvant therapy
19 Completed Iressa Expanded Access Program (EAP)
Conditions: Carcinoma;   Non-Small-Cell Lung;   Metastases;   Neoplasm
Intervention: Drug: ZD1839 (Gefitinib)
20 Completed Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease
Condition: Cystic Fibrosis
Interventions: Drug: denufosol tetrasodium (INS37217) Inhalation Solution;   Drug: Placebo - 0.9% w/v sodium chloride solution

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services